Simply Wall St.
Those who invested in Cigna Group (NYSE:CI) five years ago are up 47%
📊
AI Sentiment
Positive
6/10
- Home
- CI
as of 12-12-2025 3:41pm EST
$274.18
$2.68
-0.97%
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM and specialty pharmacy services, which were greatly expanded by its 2018 merger with Express Scripts, are mostly sold to health insurance plans and employers. Its largest PBM contract is with the Department of Defense (current contract through 2029), and it recently won a multiyear deal with top-tier insurer Centene. In health insurance and other benefits, Cigna primarily serves employers through self-funding arrangements, and the company operates mostly in the US with 17 million US and 2 million international medical members covered as of December 2024.
Chart Type:
Time Range:
| Founded: | 1792 | Country: | United States |
| Employees: | N/A | City: | BLOOMFIELD |
| Market Cap: | 76.9B | IPO Year: | N/A |
| Target Price: | $358.29 | AVG Volume (30 days): | 1.7M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 17 |
| Dividend Yield: | Dividend Payout Frequency: | Quarterly | |
| EPS: | 22.63 | EPS Growth: | 114.09 |
| 52 Week Low/High: | $239.51 - $350.00 | Next Earning Date: | 01-29-2026 |
| Revenue: | $268,077,000,000 | Revenue Growth: | 15.26% |
| Revenue Growth (this year): | 12.88% | Revenue Growth (next year): | 4.55% |
AI-Powered CI Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 2 days ago
AI Recommendation
hold
Model Accuracy: 71.33%
71.33%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Stock Insider Trading Activity of The Cigna Group (CI)
Cordani David
Buy
Chairman & CEO
CI Nov 3, 2025
Avg Cost/Share
$241.88
Shares
4,134
Total Value
$999,916.21
Owned After
157,935
SEC Form 4
Evanko Brian C
Sell
See Remarks
CI Oct 3, 2025
Avg Cost/Share
$300.00
Shares
5,368
Total Value
$1,610,400.00
Owned After
51,182
SEC Form 4
| Insider | Ticker | Relationship | Date | Transaction | Avg Cost | Shares | Total Value | Owned After | SEC Forms |
|---|---|---|---|---|---|---|---|---|---|
| Cordani David | CI | Chairman & CEO | Nov 3, 2025 | Buy | $241.88 | 4,134 | $999,916.21 | 157,935 | |
| Evanko Brian C | CI | See Remarks | Oct 3, 2025 | Sell | $300.00 | 5,368 | $1,610,400.00 | 51,182 |
Latest The Cigna Group News
CI Breaking Stock News: Dive into CI Ticker-Specific Updates for Smart Investing
The Wall Street Journal
Why a Budding Drug-Price Revolution Isn’t Quite What It Seems
➖
AI Sentiment
Neutral
5/10
Bloomberg
Senate Rejects Obamacare Credit Renewal, Teeing Up Premium Spike
📉
AI Sentiment
Negative
2/10
MT Newswires
Baird Adjusts Price Target on Cigna Group to $315 From $372, Maintains Outperform Rating
📊
AI Sentiment
Positive
7/10
Insider Monkey
Why TD Cowen Calls The Cigna Group (CI) “A Best Ideas Pick” For 2026
📈
AI Sentiment
Highly Positive
8/10
PR Newswire
The Cigna Group Foundation Awards an Additional $3 Million in Local Grants to Support Veterans' Mental Health
📈
AI Sentiment
Highly Positive
9/10
Insider Monkey
Guggenheim Stays Bullish on Cigna (CI) With Updated $318 Price Target
📈
AI Sentiment
Highly Positive
8/10
Compare CI vs Leading Stocks
See how CI stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "CI The Cigna Group - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.